{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:55:35Z","timestamp":1789991735227,"version":"4.0.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.juro.2010.06.098","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:27:19Z","timestamp":1284798439000},"page":"1947-1952","source":"Crossref","is-referenced-by-count":100,"title":["PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial"],"prefix":"10.1097","volume":"184","author":[{"given":"Sheila M.J.","family":"Aubin","sequence":"first","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Reid","sequence":"additional","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sarno","sequence":"additional","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Blase","sequence":"additional","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Aussie","sequence":"additional","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Rittenhouse","sequence":"additional","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Rittmaster","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Incorporated, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald L.","family":"Andriole","sequence":"additional","affiliation":[{"name":"Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Groskopf","sequence":"additional","affiliation":[{"name":"Gen-Probe Incorporated, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.06.098_bib1","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly over-expressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.06.098_bib2","first-page":"2695","article-title":"DD3PCA3, a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"De Kok","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.06.098_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.06.098_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2007.11.003","article-title":"A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy","volume":"389","author":"Sokoll","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.juro.2010.06.098_bib5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.098_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2010.06.098_bib7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.06.098_bib8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.098_bib9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.juro.2008.07.060","article-title":"PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume","volume":"180","author":"Whitman","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.098_bib10","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.ju.0000139320.78673.2a","article-title":"Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial","volume":"172","author":"Andriole","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.098_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver-operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.juro.2010.06.098_bib12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710040206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710040206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.06.098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:46:51Z","timestamp":1651196811000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.06.098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1016\/j.juro.2010.06.098"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.06.098","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}